Surfen dihydrochloride is a potent heparan sulfate antagonist; it binds to glycosaminoglycans, neutralizes the anticoagulant activity of unfractionated heparin and low-molecular-weight heparin, interferes with heparin sulfation and inhibits heparinase-mediated degradation, suppresses FGF2 binding and signaling, and inhibits cell adhesion and viral infection.